Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Market analyst Kevin Huddleston said news of trade deals could rebound cotton prices in late fall, and producers need to be ready to strike deals.
Texas A&M 4-H Director Montza Williams joins for an update on the expected timeline for the program’s new facility and all the associated benefits.
Shaun Haney, host of RealAg Radio, joined us to break down the latest data on Canadian farmland values and share insights on how it impacts producers.
Key signs of the U.S. beef herd’s recovery are improved pasture conditions, lower feed costs, and increased regulatory alignment and support for producers to implement targeted grazing practices.
Dr. Mark Svoboda with the National Drought Mitigation Center discusses a new global drought report and resources to help operations increase drought resilience.
